Movement Alert｜TG Therapeutics Rises 6.88% in Regular Trading, Trading at $56.5

Market Focus06-22

On June 22, TG Therapeutics rose 6.88% in regular trading, trading at $56.5 USD/share, with Turnover of $17.88 million.

Within the Biotechnology sector where TG Therapeutics belongs, among individual stocks, Apogee Therapeutics up 46.82%, AbbVie up 4.45%, Gilead Sciences up 0.05%, Regeneron Pharmaceuticals down 0.74%, Moderna down 2.76%.

TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. Its product BRIUMVI, an anti-CD20 monoclonal antibody, has been approved in the US, EU, and UK for the treatment of adult patients with relapsing forms of multiple sclerosis.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126503486?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 21:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126503486","market":"hk","top_or_hot":-1,"title":"Movement Alert｜TG Therapeutics Rises 6.88% in Regular Trading, Trading at $56.5","media":"Market Focus","content":"<p><p>On June 22, TG Therapeutics rose 6.88% in regular trading, trading at $56.5 USD/share, with Turnover of $17.88 million.</p><p>Within the Biotechnology sector where TG Therapeutics belongs, among individual stocks, Apogee Therapeutics up 46.82%, AbbVie up 4.45%, Gilead Sciences up 0.05%, Regeneron Pharmaceuticals down 0.74%, Moderna down 2.76%.</p><p>TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. Its product BRIUMVI, an anti-CD20 monoclonal antibody, has been approved in the US, EU, and UK for the treatment of adult patients with relapsing forms of multiple sclerosis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜TG Therapeutics Rises 6.88% in Regular Trading, Trading at $56.5</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜TG Therapeutics Rises 6.88% in Regular Trading, Trading at $56.5\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-22 21:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 22, TG Therapeutics rose 6.88% in regular trading, trading at $56.5 USD/share, with Turnover of $17.88 million.</p><p>Within the Biotechnology sector where TG Therapeutics belongs, among individual stocks, Apogee Therapeutics up 46.82%, AbbVie up 4.45%, Gilead Sciences up 0.05%, Regeneron Pharmaceuticals down 0.74%, Moderna down 2.76%.</p><p>TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. Its product BRIUMVI, an anti-CD20 monoclonal antibody, has been approved in the US, EU, and UK for the treatment of adult patients with relapsing forms of multiple sclerosis.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TGTX","symbol_name":"TG Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1126503486","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126503486","pubTimestamp":1782136292,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 22, TG Therapeutics rose 6.88% in regular trading, trading at $56.5 USD/share, with Turnover of $17.88 million.Within the Biotechnology sector where TG Therapeutics belongs, among individual...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TGTX":"TG Therapeutics Inc."},"translate_title":"走势提示|TG Therapeutics常规交易上涨6.88%，报56.5美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TGTX":1},"content_text":"On June 22, TG Therapeutics rose 6.88% in regular trading, trading at $56.5 USD/share, with Turnover of $17.88 million.Within the Biotechnology sector where TG Therapeutics belongs, among individual stocks, Apogee Therapeutics up 46.82%, AbbVie up 4.45%, Gilead Sciences up 0.05%, Regeneron Pharmaceuticals down 0.74%, Moderna down 2.76%.TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. Its product BRIUMVI, an anti-CD20 monoclonal antibody, has been approved in the US, EU, and UK for the treatment of adult patients with relapsing forms of multiple sclerosis.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126503486","isCrawlerRequest":true}